Serum concentration of asprosin in new-onset type 2 diabetes

BACKGROUND: Asprosin, a newly identified adipokine, is pathologically increased in individuals with insulin resistance. However, the available evidence on the association of asprosin and type 2 diabetes mellitus (T2DM) status is still scarce. Therefore, this study aimed to determine the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Naiemian, Shakiba, Naeemipour, Mohsen, Zarei, Mehdi, Lari Najafi, Moslem, Gohari, Ali, Behroozikhah, Mohammad Reza, Heydari, Hafez, Miri, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376837/
https://www.ncbi.nlm.nih.gov/pubmed/32714446
http://dx.doi.org/10.1186/s13098-020-00564-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376837/
https://www.ncbi.nlm.nih.gov/pubmed/32714446
http://dx.doi.org/10.1186/s13098-020-00564-w

Ejemplares similares